<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Reason for Visit</a></li><li><a href="#id2">Encounter Details</a></li><li><a href="#id3">Social History</a></li><li><a href="#id4">Last Filed Vital Signs</a></li><li><a href="#id5">Progress Notes</a></li><li><a href="#id6">Plan of Treatment</a></li><li><a href="#id7">Visit Diagnoses</a></li><li><a href="#id8">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Reason for Visit</a></h3><div><ul><li><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Reason</th><th>Comments</th></tr></thead><tbody><tr ID="rfv2"><td ID="reasonrfv2">Follow-up</td><td/></tr></tbody></table></li><li> (Routine) - Closed: <table><colgroup><col width="25%" span="4"/></colgroup><thead><tr><th>Specialty</th><th>Diagnoses / Procedures</th><th>Referred By Contact</th><th>Referred To Contact</th></tr></thead><tbody><tr><td>Hematology &amp; Oncology / Hematology and Oncology</td><td><p>Diagnoses</p><p>3 month OV f2f</p><br/><p>Procedures</p><p>HEMONC EPV</p></td><td><p>[REDACTED] R, MD</p><p>[REDACTED][REDACTED]</p><p>STE A</p><p>[REDACTED]</p><p>Phone: tel:[REDACTED]</p><p>fax:[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>Ste 101A</p><p>[REDACTED]</p><p>Phone: tel:[REDACTED]</p><p>fax:[REDACTED]</p></td></tr></tbody></table><table><colgroup><col width="13%"/><col width="12%"/><col width="25%"/><col width="13%"/><col width="12%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Referral ID</th><th>Status</th><th>Reason</th><th>Start Date</th><th>Expiration Date</th><th>Visits Requested</th><th>Visits Authorized</th></tr></thead><tbody><tr><td>9402362</td><td class="xflagData">Closed</td><td/><td>[REDACTED]</td><td>[REDACTED]</td><td>99</td><td>99</td></tr></tbody></table><br/></li></ul></div><h3><a name="id2" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter4" class="xRowNormal"><td>[REDACTED]  8:30 AM EDT</td><td ID="encounter4type">Office Visit</td><td><p>Cancer Center of [REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]-3443</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>Ste 101A</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><br/><p>[REDACTED], APRN</p><p>[REDACTED]</p><p>Ste 200</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td><content>Invasive ductal carcinoma of right breast (HC CODE) (Primary Dx); <br/>Monoclonal paraproteinemia</content></td></tr></tbody></table></div><h3><a name="id3" href="#toc">Social History</a></h3><div><table ID="sochist10"><colgroup><col width="25%" span="2"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Former</td><td>Cigarettes</td><td ID="sochist10packsperday"/><td/><td>Quit: 2022</td></tr><tr ID="sochist10smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><tbody><tr><td ID="sochist10cessation" class="xnoIndent"><span class="xcellHeader">Tobacco Cessation:</span> Counseling Given: No<br/></td></tr></tbody></table><table><colgroup><col width="25%" span="2"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">Not Currently</td><td>0 (1 standard drink = 0.6 oz pure alcohol)</td><td>socially</td></tr></tbody></table><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Pregnant</th><th>Comments</th></tr></thead><tbody><tr><td>Unknown</td><td/></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex13"><td>Sex Assigned at Birth</td><td ID="BirthSex13Value">Not on file</td><td/></tr><tr ID="LegalSex14"><td>Legal Sex</td><td ID="LegalSex14Value">Female</td><td>[REDACTED] 12:46 PM EST</td></tr><tr ID="GenderIdentity11"><td>Gender Identity</td><td ID="GenderIdentity11Value">Not on file</td><td/></tr><tr ID="SexualOrientation12"><td>Sexual Orientation</td><td ID="SexualOrientation12Value">Not on file</td><td/></tr></tbody></table>documented as of this encounter</div><h3><a name="id4" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col width="25%" span="4"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">123</span>/<span class="content_span">69</span></td><td>[REDACTED]  8:16 AM EDT</td><td/></tr><tr ID="pulse_5765602560" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>87</td><td>[REDACTED]  8:16 AM EDT</td><td/></tr><tr ID="temp_5765602560" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>36.1 °C (96.9 °F)</td><td>[REDACTED]  8:16 AM EDT</td><td/></tr><tr ID="resp_5765602560" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>16</td><td>[REDACTED]  8:16 AM EDT</td><td/></tr><tr ID="SpO2_5765602560" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>93%</td><td>[REDACTED]  8:16 AM EDT</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5765602560" class="xRowNormal"><td class="xcellHeader">Weight</td><td>123.4 kg (272 lb)</td><td>[REDACTED]  8:16 AM EDT</td><td/></tr><tr ID="height_5765602560" class="xRowAlt"><td class="xcellHeader">Height</td><td>175.3 cm (5' 9")</td><td>[REDACTED]  8:16 AM EDT</td><td/></tr><tr ID="bmi_5765602560" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>40.17</td><td>[REDACTED]  8:16 AM EDT</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id5" href="#toc">Progress Notes</a></h3><div><ul><li>[REDACTED], APRN - [REDACTED]  8:30 AM EDT: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/><span class="xLabel">Images from the original note were not included.</span><br/>Transcription Complete: Yes<br/> <br/><br/>Patient: [REDACTED]  <br/>MR Number: 101061847 <br/>Date of Birth:  [REDACTED]  <br/>Date of Visit:  [REDACTED]  <br/><br/>Chief Complaint <br/>Patient presents with <br/> Follow-up <br/> <br/>HPI<br/>[REDACTED] Few is a [REDACTED]. female diagnosed in [REDACTED] with a stage I (T1b N0) invasive ductal carcinoma of the right breast, ER/PR positive and HER2 positive, status post lumpectomy and adjuvant chemotherapy as well as adjuvant Femara, also with polycythemia likely due to hypoxia and tobacco use. In [REDACTED] patient was diagnosed with a recurrent right-sided invasive ductal carcinoma, T2 N0, ER/PR positive and HER2 positive.  She is s/p adjuvant AC-THP followed by 1 year of Herceptin/Perjeta maintenance and currently on letrozole.<br/>.<br/>HEM/ONC HX:<br/>A [REDACTED]. female originally diagnosed in [REDACTED] with a stage I (T1b N0) grade 2 invasive ductal carcinoma, ER/PR positive and HER2 positive. She underwent lumpectomy with axillary dissection 2009. This was followed by chemotherapy with TCH which was poorly tolerated. She was placed on tamoxifen which was not tolerated well and then was able to tolerate Femara for 5 years.<br/>In [REDACTED], she was found to have a meningioma for which she underwent gamma knife procedure. In terms of her breast cancer, she has been on surveillance. Her last mammogram was in [REDACTED] where she had mammo and ultrasound that were both negative.<br/>[REDACTED] - Bilateral mammo and ultrasound BI-RADS 2<br/>01/2019 - Patient seen in our office and was told that she might have iron overload. At that point, we had looked at her labs from [REDACTED] and she had normal ferritin of 19 and iron saturation of 15%. Hemachromatosis gene panel was also negative<br/>[REDACTED] - HGB 15.9, HCT 50.2, PLT 233, WBC 7.3<br/>[REDACTED] - Flow cytometry is negative for a lymphoproliferative disorder. Iron level shows an iron sat of 12%, ferritin 11, both low, EPO level is elevated at 33.4 <br/>[REDACTED] - JAK2 mutation negative<br/>[REDACTED] - CBC shows WBC 6.8, HGB 16.3, HCT 51, PLT 228, MCV 86.4, iron 80, % sat 23, ferritin 14, LDH 119 (normal), CMP unremarkable <br/>[REDACTED] - WBC 7.2, HGB 17.6, HCT 51.7, PLT 176, MCV 87.1<br/>12/2019 - Left mammo and ultrasound negative BI-RADS 2<br/>[REDACTED] - HGB 17.5, HCT 52, iron sat 23%, ferritin 18<br/>[REDACTED] - Bilateral mammogram and ultrasound BI-RADS 2<br/>[REDACTED] - HGB 18, HCT 54.7<br/>[REDACTED] - WBC 6.5, ANC 3.57, HGB 17.3, HCT 51.5, PLT 209<br/>[REDACTED] - WBC 6.41, HGB 17.5, HCT 52.3, PLT 200<br/>[REDACTED] - Brain MRI - no acute intracranial pathology. Stable right CP angle region extra-axial mass add up to 1.4 cm, can be consistent with patient's known meningioma. White matter signal abnormalities are nonspecific in nature. Opacified left and partially opacified right petrous mastoid air cells. Bilateral proptosis is a subtle change in the interim<br/>[REDACTED] - Mammogram done at Good [REDACTED] outpatient imaging at [REDACTED] - new 1.7 cm microlobulated spiculated mass adjacent to the periareolar scar from her prior lumpectomy; no suspicious left breast findings.  Ultrasound - suspicious right periareolar 1.7 cm mass, otherwise stable.  Patient was recommended for biopsy<br/>[REDACTED] - Right breast subareolar 3 o'clock biopsy reveals invasive ductal carcinoma moderately differentiated, ER positive, PR positive, and HER2 positive at 3+<br/>2/2022 - PET negative for metastatic disease<br/>[REDACTED] - Left mastectomy is negative, 0/1 left nodes involved.  Right mastectomy reveals a 3.5 cm invasive ductal carcinoma, LVI present, grade 2, 0/3 lymph nodes involved, ER positive 98%, PR positive 20%, HER2 positive 3+, Ki-67 30%<br/>[REDACTED] - ADDENDUM reports of Left axillary sentinel lymph node: IgA lambda-restricted lymphoplasmacytic population. Negative for BCL6/BCL2 and MYD88 L265P <br/>[REDACTED] - C1 DDAC<br/>[REDACTED] - C2 DDAC <br/>[REDACTED] - C3 D1 DD AC ( dose reduce Adria to 50 mg/m2) <br/>[REDACTED] - C4 D1 DD AC (dose reduce Adria to 50 mg/m2)<br/>[REDACTED] - C1D1 THP<br/>[REDACTED] - C2D1 THP <br/>[REDACTED] - Patient missed day 8 and day 15 of her cycle 2 of weekly Taxol.  She was found to be COVID positive on 07/24 with cough, fatigue and weakness<br/>[REDACTED] - C3D1 THP<br/>[REDACTED] - C4 THP<br/>[REDACTED] - Start letrozole<br/>10/2022 - Echo - EF 55-60%<br/>[REDACTED] - RUQ ultrasound shows no evidence of acute cholecystitis, there is increased liver parenchymal echogenicity.<br/>[REDACTED] - BMD is normal <br/>[REDACTED] - Echo 55-60%<br/>[REDACTED] - CT ABD/PEL - no acute pathology identified in the abdomen or pelvis.  Right adrenal myelolipoma.  Left adrenal nodularity at 2.9 cm.  An MRI abdomen would be advised to attempt further characterization.  Bilateral renal cysts.  Subcentimeter right renal angio myolipoma.  Mild atherosclerotic vascular calcifications.  Sigmoid colonic diverticulosis.  Fecal loading my reflect constipation.  1.8 cm peripherally sclerotic lesion in the L3 vertebral body.  Recommend obtaining a nuclear medicine whole body bone scan to further evaluate <br/>[REDACTED]- bone scan negative <br/>[REDACTED]- MR Abdomen: 1.9cm L adrenal nodular fullness may be lipid poor adenoma <br/>[REDACTED] - Completed 1 year of Herceptin/Perjeta<br/><br/>INTERIM HISTORY<br/>The patient remains on letrozole and does report joint pains. She reports that these are tolerable. She has no new systemic complaints at this time.  <br/><br/>Current Medications  <br/><br/>   Dosage <br/> albuterol (PROVENTIL HFA;VENTOLIN HFA; PROAIR HFA) 90 mcg/actuation inhaler Inhale into the lungs. <br/> ALPRAZolam (XANAX) 2 mg tablet TAKE 1 TABLET BY MOUTH TWICE DAILY AS NEEDED FOR ANXIETY FOR 30 DAYS <br/> atorvastatin (LIPITOR) 20 mg tablet  <br/> buPROPion (WELLBUTRIN SR) 150 mg 12 hr tablet TAKE 1 TABLET BY MOUTH ONCE DAILY FOR FIRST WEEK, THEN TAKE 1 TABLET TWICE DAILY <br/> dexAMETHasone (DECADRON) 4 mg tablet Take 2 tablets in am x 3 days, starting day after each AC chemo <br/> escitalopram oxalate (LEXAPRO) 20 mg tablet Take 20 mg total (1 tablet) by mouth daily. <br/> furosemide (LASIX) 40 mg tablet TAKE 1 TABLET BY MOUTH ONCE DAILY FOR 90 DAYS <br/> glipiZIDE (GLUCOTROL) 5 mg tablet Take by mouth. <br/> HYDROcodone-acetaminophen (NORCO) 5-325 mg per tablet hydrocodone 5 mg-acetaminophen 325 mg tablet <br/> letrozole (FEMARA) 2.5 mg tablet Take 2.5 mg total (1 tablet) by mouth daily. <br/> lidocaine-prilocaine (EMLA) cream Apply topically as needed. Apply 1 hour prior to port access <br/> LORazepam (ATIVAN) 1 mg tablet Take 1 mg total (1 tablet) by mouth every 8 (eight) hours as needed for Anxiety (nausea, or sleep). <br/> losartan (COZAAR) 25 mg tablet Take by mouth. <br/> magnesium chloride (Slow-Mag) 71.5 mg Take 71.5 mg total (1 tablet) by mouth daily. <br/> meclizine (ANTIVERT) 25 mg tablet Take by mouth. <br/> metFORMIN (GLUCOPHAGE) 500 mg tablet Take by mouth. <br/> methylPREDNISolone (MEDROL) 4 mg tablet follow package directions <br/> NIFEdipine (ADALAT CC) 60 mg 24 hr tablet TAKE 1 TABLET BY MOUTH ONCE DAILY FOR 90 DAYS <br/> Nystop powder APPLY 1 APPLICATION TOPICALLY THREE TIMES DAILY AS NEEDED FOR 20 DAYS <br/> omeprazole (PRILOSEC OTC) 20 mg tablet 1 mg daily. <br/> omeprazole (PRILOSEC) 20 mg capsule TAKE 1 CAPSULE BY MOUTH ONCE DAILY FOR 90 DAYS <br/> ondansetron (ZOFRAN) 8 mg tablet Take 8 mg total (1 tablet) by mouth every 8 (eight) hours as needed for Nausea. <br/> oxyCODONE-acetaminophen (PERCOCET) 5-325 mg per tablet TAKE 1 TABLET BY MOUTH EVERY 6 HOURS FOR PAIN FOR 30 DAYS <br/> potassium chloride SA (K-DUR,KLOR-CON) 20 mEq tablet Take 20 mEq total (1 tablet) by mouth daily. <br/> prochlorperazine (COMPAZINE) 10 mg tablet Take 10 mg total (1 tablet) by mouth every 6 (six) hours as needed. <br/> Symbicort 160-4.5 mcg/actuation inhaler INHALE 2 PUFFS BY MOUTH TWICE DAILY <br/> topiramate (TOPAMAX) 50 mg tablet topiramate 50 mg tablet <br/> traZODone (DESYREL) 300 mg tablet TAKE 1 TABLET BY MOUTH EVERY DAY AT BEDTIME <br/> True Metrix Air Glucose Meter Misc  <br/> True Metrix Glucose Test Strip test strip SMARTSIG:Via Meter <br/> venlafaxine (EFFEXOR) 75 mg tablet venlafaxine 75 mg tablet <br/><br/> <br/> <br/><br/>Allergies <br/>Allergen Reactions <br/> Penicillins  <br/> <br/><br/>Past Medical History: <br/>Diagnosis Date <br/> Breast cancer (HC CODE)  <br/> Colon polyp  <br/> COPD (chronic obstructive pulmonary disease) (HC CODE)  <br/> Depression  <br/> Hemorrhoid  <br/> Hyperlipidemia  <br/> Hypertension  <br/> Meningioma (HC CODE)  <br/><br/>Past Surgical History: <br/>Procedure Laterality Date <br/> BREAST LUMPECTOMY   <br/> Gamma knife <br/> COLONOSCOPY   <br/> MASTECTOMY   <br/> <br/><br/>Family History <br/>Problem Relation Age of Onset <br/> Diabetes Mother  <br/> Heart disease Father  <br/> Brain cancer Sister  <br/> <br/><br/>Social History <br/><br/>Tobacco Use <br/> Smoking status: Former <br/>  Packs/day: 0.50 <br/>  Types: Cigarettes <br/>  Quit date: 2022 <br/>  Years since quitting: 1.7 <br/> Smokeless tobacco: Never <br/>Vaping Use <br/> Vaping Use: Never used <br/>Substance Use Topics <br/> Alcohol use: Not Currently <br/>  Comment: socially <br/> Drug use: Never <br/> <br/>OB History  <br/><br/> Gravida <br/>2 <br/> Para <br/>2 <br/> Term <br/>  <br/> Preterm <br/>  <br/> AB <br/>  <br/> Living <br/>  <br/> <br/><br/> SAB <br/>  <br/> IAB <br/>  <br/> Ectopic <br/>  <br/> Multiple <br/>  <br/> Live Births <br/>  <br/>  <br/> <br/> <br/><br/>GYN History<br/>Age at Menarche: 16<br/>Age at First Pregnancy: 35<br/>Age at Menopause: 49, when starting chemo<br/><br/>Review of Systems <br/>Constitutional: <br/>     As per hem/onc hx <br/>HENT: Negative.  <br/>Eyes: Negative.  <br/>Respiratory: Negative.  <br/>Cardiovascular: Negative.  <br/>Gastrointestinal: Negative.  <br/>Genitourinary: Negative.  <br/>Musculoskeletal: Negative.  <br/>Skin: Negative.  <br/>Neurological: Negative.  <br/>Endo/Heme/Allergies: Negative.  <br/>Psychiatric/Behavioral: Negative.  <br/>All other systems reviewed and are negative.<br/><br/>Vitals: <br/> [REDACTED] 0816 <br/>BP: 123/69 <br/>Pulse: 87 <br/>Resp: 16 <br/>Temp: 96.9 °F (36.1 °C) <br/>TempSrc: Temporal <br/>SpO2: 93% <br/>Weight: (!) 123.4 kg (272 lb) <br/>Height: 175.3 cm (5' 9") <br/>PainSc: 0 - No pain  <br/><br/>Body mass index is 40.17 kg/m².<br/><br/>GENERAL APPEARANCE: no acute distress <br/>EYES: conjunctiva and lids normal, PERRLA <br/>EARS: WNL <br/>NOSE: WNL <br/>ORAL CAVITY: oral exam WNL<br/>THROAT: WNL<br/>NECK/THYROID: supple, no JVD<br/>LYMPH NODES: no anterior or posterior cervical, supraclavicular, or axillary adenopathy <br/>SKIN: s/p B mastectomy <br/>HEART: regular rate and rhythm<br/>LUNGS: clear to auscultation bilaterally <br/>CHEST: no masses, tenderness; no asymmetry <br/>BREASTS: s/p bilateral mastectomy, well healed, no abnormalities <br/>ABDOMEN: RUQ tender on palpation <br/>MUSCULOSKELETAL: no acute joint swelling, effusions <br/>EXTREMITIES: no clubbing, cyanosis <br/>NEUROLOGIC: normal mental status, CN 2-12 intact <br/>PSYCH: alert; oriented to person, place, and time<br/><br/>DIAGNOSES<br/>1. Invasive ductal carcinoma of right breast (HC CODE)   <br/> <br/>2. Monoclonal paraproteinemia   <br/> <br/><br/>ASSESSMENT/PLAN <br/>This is a [REDACTED]. female with history of a stage I, ER positive, HER2 positive, right-sided breast cancer in [REDACTED], status post lumpectomy, adjuvant chemotherapy and 5 years of endocrine therapy with Femara. <br/><br/>Patient's mammogram [REDACTED] showed a new 1.7 cm mass adjacent to the surgical scar.  Biopsy proven to be invasive ductal carcinoma, grade 2, ER/PR positive, HER2 positive.  Patient underwent partial mastectomy on [REDACTED].  Right breast was found to have a T2 N0, grade 2, with LVI, invasive ductal carcinoma.  Left breast within normal limits.  <br/><br/>In the past the patient had Taxotere, carbo and trastuzumab from what I can gather. Therefore, we decided to treat with AC followed by Taxol, trastuzumab and Perjeta. <br/> <br/>She is s/p 4 cycles of dose dense AC, and 9 weeks of Taxol, 4 cycles of HP followed by 1 year of trastuzumab and Perjeta. Due to her right mastectomy with negative SNL she did not proceed with RT.  <br/><br/>She is currently on letrozole, overall tolerating well with expected side effects.  She will continue this for a total of 5 years.  Recent bone density is normal repeat in [REDACTED].   <br/><br/>No signs or symptoms of recurrence on exam.<br/><br/>All questions were answered. We will see her back in about 6 months in follow up.<br/> <br/><br/>Lastly, in regards to her IgA lambda restricted lymphoplasmacytic population path from left axillary sentinel lymph node, she is being followed by [REDACTED].  <br/><br/>She is in agreement with the plan and knows to call the office if she has any questions or concerns in the interim. <br/><br/>Total time spent face to face was over 30 minutes, , out of which more than 50% of the time was spent counseling the above and coordinating care.<br/><br/>[REDACTED] APRN<br/>[REDACTED] MD<br/><br/>cc: [REDACTED]<br/><br/>njm<br/><br/>Return in about 6 months (around [REDACTED]) for f/u with Dr [REDACTED]. <br/><br/></content><br/><span class="xLabel">Electronically signed by [REDACTED], APRN at [REDACTED]  8:55 AM EDT</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id6" href="#toc">Plan of Treatment</a></h3><div><p>Not on file</p>documented as of this encounter</div><h3><a name="id7" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx5" class="xRowNormal"><td><p><span class="content_span">Invasive ductal carcinoma of right breast (HC CODE)</span><span class="content_span"> - Primary</span></p></td></tr><tr ID="vdx6" class="xRowAlt"><td><p><span class="content_span">Monoclonal paraproteinemia</span></p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id8" href="#toc">Care Teams</a></h3><div><table ID="ct43"><colgroup><col width="25%" span="3"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>[REDACTED] R, MD</p><p>NPI: [REDACTED]</p><p>[REDACTED]</p><p>STE A</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>PCP - General</td><td>Internal Medicine</td><td>[REDACTED]</td><td/></tr><tr class="xRowAlt"><td><p>[REDACTED] R, MD</p><p>NPI: [REDACTED]</p><p>[REDACTED][REDACTED]</p><p>STE A</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/><td>Internal Medicine</td><td>[REDACTED]</td><td/></tr><tr class="xRowNormal"><td><p>[REDACTED][REDACTED], MD</p><p>NPI: [REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>Consulting Physician</td><td>Hematology &amp; Oncology</td><td>[REDACTED]</td><td/></tr><tr class="xRowAlt"><td><p>[REDACTED]</p><p>1 TGH CIRCLE</p><p>[REDACTED], FL 33606-3571</p><p>[REDACTED] (Work)</p></td><td>Oncology Navigator</td><td/><td>[REDACTED]</td><td/></tr><tr class="xRowNormal"><td><p>[REDACTED], MD</p><p>NPI: [REDACTED]</p><p>[REDACTED][REDACTED]</p><p>STE 104</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>Consulting Physician</td><td>Gastroenterology</td><td>[REDACTED]</td><td/></tr></tbody></table>documented as of this encounter</div><br/><br/>
</body></html>